PRELUDE CAPITAL MANAGEMENT, LLC - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 79 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$316,000
+83.7%
42,334
+71.3%
0.03%
+42.9%
Q4 2016$172,000
-34.6%
24,718
-22.6%
0.02%
-22.2%
Q3 2016$263,000
+3187.5%
31,945
+3094.5%
0.03%
+2600.0%
Q2 2016$8,000
-90.5%
1,000
-93.9%
0.00%
-91.7%
Q1 2016$84,000
+147.1%
16,500
+345.9%
0.01%
+140.0%
Q2 2015$34,000
+126.7%
3,700
+208.3%
0.01%
+150.0%
Q1 2015$15,0001,2000.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q1 2016
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 3,180,913$18,322,0004.76%
ACUTA CAPITAL PARTNERS, LLC 1,314,959$7,574,0004.38%
Perceptive Advisors 5,910,912$34,046,0001.36%
P.A.W. CAPITAL CORP 200,000$1,152,0001.32%
Ghost Tree Capital, LLC 300,000$1,728,0000.78%
Broadfin Capital, LLC 2,105,519$12,128,0000.68%
Rhenman & Partners Asset Management AB 683,108$3,935,0000.63%
Trellus Management Company, LLC 60,539$349,0000.51%
Cormorant Asset Management, LP 499,815$2,879,0000.46%
QVT Financial LP 1,433,700$8,258,0000.28%
View complete list of LION BIOTECHNOLOGIES INC shareholders